Michael Oquinn, MD
Clinical Cardiac Electrophysiology · Spartanburg, SCNPI 1073807541
Payments from drug & device makers
Across 456 payments — averaging $154.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$30K
- Biotronik Inc.$19K
- Cardiofocus, Inc.$7K
- Boston Scientific$4K
- Atricure, Inc.$3K
- Abbott$2K
- plus $5K from 31 others
What the payments were for
- Speaking & faculty fees$2,0003%
- Grants$25,00036%
- Travel & lodging$27,34439%
- Food & beverage$15,65822%
- Education$2820%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 61 | $30,271 |
| Biotronik Inc. | 106 | $19,295 |
| Cardiofocus, Inc. | 3 | $7,068 |
| Boston Scientific | 44 | $4,209 |
| Atricure, Inc. | 36 | $2,879 |
| Abbott | 37 | $1,514 |
| Biosense Webster, Inc. | 58 | $1,147 |
| Medical Device Business Services, Inc. | 4 | $726 |
| CMS Imaging, Inc. | 2 | $368 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $341 |
| Impulse Dynamics (USA) Inc. | 4 | $332 |
| Vektor Medical Inc. | 1 | $252 |
| Novartis | 14 | $241 |
| Cardiva Medical, Inc. | 5 | $169 |
| Pfizer | 8 | $142 |
| Cardiovascular Systems Inc. | 2 | $125 |
| AstraZeneca | 9 | $116 |
| Cordis US CORP. | 1 | $114 |
| Cvrx, Inc. | 13 | $112 |
| Johnson & Johnson | 6 | $107 |
| Asahi Intecc USA, Inc. | 1 | $100 |
| Abiomed | 4 | $87 |
| E.r. Squibb & Sons, L.L.C. | 3 | $73 |
| Merck | 4 | $72 |
| Inari Medical, Inc. | 3 | $70 |
| Boehringer Ingelheim | 3 | $70 |
| Chiesi USA, Inc. | 3 | $48 |
| Angiodynamics, Inc. | 1 | $47 |
| Philips North America LLC | 1 | $39 |
| Recor Medical Inc | 1 | $25 |
| Amgen | 2 | $25 |
| Edwards Lifesciences | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Bayer | 1 | $16 |
| Getinge USA Sales, LLC | 1 | $15 |
| Terumo Medical Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioMonitor$4,913
- Solia$4,787
- Acticor 7 VR-T DX$4,666
- Rivacor 7 DR-T$3,864
- Edora 8 DR-T$3,745
- Orsiro$2,284
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,617
- Watchman$1,238
- Rivacor$1,042
- Edora$1,042
- Acticor$1,042
- Carto 3$986
- OPTIMIZER$580
- SYNERGY ABLATION SYSTEM$519
- AMVIA EDGE$513
- ENSITE PRECISION$307
- WATCHMAN FLX$254
- LifeVest$208
- Ensite Cardiac Mapping System$185
- Micra$163
How this compares
$70,284 in reported general payments places this provider in the 55th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.
See all clinical cardiac electrophysiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 125 | $115,583 |
| MultaqDronedarone Hcl | 25 | $24,840 |
| XareltoRivaroxaban | 31 | $20,993 |
| Metoprolol Succinate | 121 | $1,063 |
| Flecainide Acetate | 24 | $820 |
| Mupirocin | 83 | $636 |
| ClopidogrelClopidogrel Bisulfate | 54 | $386 |
| Amiodarone Hcl | 31 | $358 |
| Metoprolol Tartrate | 51 | $257 |
| Carvedilol | 44 | $249 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 23 | $122 |
| Lisinopril | 15 | $109 |
| Amlodipine Besylate | 20 | $100 |
| Benazepril Hcl | 11 | $64 |
| Furosemide | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $142 | $115,583125 claims |
| Johnson & JohnsonXarelto | $107 | $20,99331 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 58 clinical cardiac electrophysiology providers in South Carolina.
Other clinical cardiac electrophysiology in Spartanburg
- Asif JafferaniSpartanburg$14K
- Jeff BerrySpartanburg$10K
- Frank CuocoCharleston$2.8M
- Jeffrey WinterfieldCharleston$2.2M
- Michael FieldMoncks Corner$1.3M
- Andrew BrenyoRock Hill$527K
- Jeffrey SenfieldGreenville$517K
- Michael GoldCharleston$359K
- Sultan SiddiqueColumbia$328K
- Chad WardClemson$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.